These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 9705836

  • 1. Monoclonal antibodies to human thioredoxin reductase.
    Söderberg A, Sahaf B, Holmgren A, Rosén A.
    Biochem Biophys Res Commun; 1998 Aug 10; 249(1):86-9. PubMed ID: 9705836
    [Abstract] [Full Text] [Related]

  • 2. Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities.
    Gorlatov SN, Stadtman TC.
    Arch Biochem Biophys; 1999 Sep 01; 369(1):133-42. PubMed ID: 10462449
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of thioredoxin reductase 1 regulates NF-kappa B activation.
    Sakurai A, Yuasa K, Shoji Y, Himeno S, Tsujimoto M, Kunimoto M, Imura N, Hara S.
    J Cell Physiol; 2004 Jan 01; 198(1):22-30. PubMed ID: 14584040
    [Abstract] [Full Text] [Related]

  • 4. Ebselen: a substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant.
    Zhao R, Masayasu H, Holmgren A.
    Proc Natl Acad Sci U S A; 2002 Jun 25; 99(13):8579-84. PubMed ID: 12070343
    [Abstract] [Full Text] [Related]

  • 5. Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma.
    Söderberg A, Sahaf B, Rosén A.
    Cancer Res; 2000 Apr 15; 60(8):2281-9. PubMed ID: 10786696
    [Abstract] [Full Text] [Related]

  • 6. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.
    Soini Y, Kahlos K, Näpänkangas U, Kaarteenaho-Wiik R, Säily M, Koistinen P, Pääakkö P, Holmgren A, Kinnula VL.
    Clin Cancer Res; 2001 Jun 15; 7(6):1750-7. PubMed ID: 11410516
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. On the potential of thioredoxin reductase inhibitors for cancer therapy.
    Urig S, Becker K.
    Semin Cancer Biol; 2006 Dec 15; 16(6):452-65. PubMed ID: 17056271
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
    Lu J, Papp LV, Fang J, Rodriguez-Nieto S, Zhivotovsky B, Holmgren A.
    Cancer Res; 2006 Apr 15; 66(8):4410-8. PubMed ID: 16618767
    [Abstract] [Full Text] [Related]

  • 10. Revival of glutathione reductase in human cataractous and clear lens extracts by thioredoxin and thioredoxin reductase, in conjunction with alpha-crystallin or thioltransferase.
    Yan H, Harding JJ, Xing K, Lou MF.
    Curr Eye Res; 2007 May 15; 32(5):455-63. PubMed ID: 17514531
    [Abstract] [Full Text] [Related]

  • 11. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2.
    Sakurai A, Nishimoto M, Himeno S, Imura N, Tsujimoto M, Kunimoto M, Hara S.
    J Cell Physiol; 2005 Jun 15; 203(3):529-37. PubMed ID: 15521073
    [Abstract] [Full Text] [Related]

  • 12. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles.
    Cassidy PB, Edes K, Nelson CC, Parsawar K, Fitzpatrick FA, Moos PJ.
    Carcinogenesis; 2006 Dec 15; 27(12):2538-49. PubMed ID: 16777982
    [Abstract] [Full Text] [Related]

  • 13. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
    Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Ekindjian OG, Kahan A, Borderie D.
    Clin Chim Acta; 2006 May 15; 367(1-2):156-61. PubMed ID: 16458876
    [Abstract] [Full Text] [Related]

  • 14. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
    Wang X, Zhang J, Xu T.
    Toxicol Appl Pharmacol; 2007 Jan 01; 218(1):88-95. PubMed ID: 17156807
    [Abstract] [Full Text] [Related]

  • 15. Thioredoxin reductase-thioredoxin fusion enzyme from Mycobacterium leprae: comparison with the separately expressed thioredoxin reductase.
    Wang PF, Marcinkeviciene J, Williams CH, Blanchard JS.
    Biochemistry; 1998 Nov 17; 37(46):16378-89. PubMed ID: 9819230
    [Abstract] [Full Text] [Related]

  • 16. Thioredoxin, thioredoxin reductase, and alpha-crystallin revive inactivated glyceraldehyde 3-phosphate dehydrogenase in human aged and cataract lens extracts.
    Yan H, Lou MF, Fernando MR, Harding JJ.
    Mol Vis; 2006 Oct 02; 12():1153-9. PubMed ID: 17093401
    [Abstract] [Full Text] [Related]

  • 17. [Thioredoxin reductase--a new target for molecular medical investigations].
    Zagrodzki P.
    Postepy Hig Med Dosw; 2002 Oct 02; 56(2):155-67. PubMed ID: 12107960
    [Abstract] [Full Text] [Related]

  • 18. Development and partial characterization of high-affinity monoclonal antibodies for botulinum toxin type A and their use in analysis of milk by sandwich ELISA.
    Stanker LH, Merrill P, Scotcher MC, Cheng LW.
    J Immunol Methods; 2008 Jul 20; 336(1):1-8. PubMed ID: 18452945
    [Abstract] [Full Text] [Related]

  • 19. Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunization.
    Leinonen J, Niemelä P, Lövgren J, Bocchi L, Pettersson K, Nevanlinna H, Stenman UH.
    J Immunol Methods; 2004 Jun 20; 289(1-2):157-67. PubMed ID: 15251421
    [Abstract] [Full Text] [Related]

  • 20. Thioredoxin and thioredoxin reductase: current research with special reference to human disease.
    Holmgren A, Lu J.
    Biochem Biophys Res Commun; 2010 May 21; 396(1):120-4. PubMed ID: 20494123
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.